(CercleFinance.com) – UBS raises its recommendation on Arkema from ‘neutral’ to ‘buy’ with a price target raised from 95 to 120 euros, a new target which contains a potential increase of 31% for the group’s stock. French chemistry.
The broker highlights a recovery in EBITDA and a conversion of around 50% of free cash flow. ‘The FCF yield of 13% per year is the highest in the European diversified sub-sector,’ he also underlines in the summary of his research note.
Copyright © 2023 CercleFinance.com. All rights reserved.
The information and analyzes distributed by Cercle Finance only constitute a decision-making aid for investors. Cercle Finance cannot be held responsible directly or indirectly following the use of information and analyzes by readers. It is recommended that any uninformed person consult a professional advisor before making any investment. This indicative information does not in any way constitute an inducement to sell or a solicitation to buy.
Did you like this article ? Share it with your friends using the buttons below.
